Juventas Cell Therapy Ltd.
PrivateLast Round
Series C
Jul 12, 2021
Est. Valuation
$263.04M
Total Funding Raised
$169.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Juventas Cell Therapy Ltd. operates in Healthcare & Life Sciences and is based in Tianjin. Its latest recorded funding round was a Series C round in July 2021.
Juventas Cell Therapy Ltd. is a biotechnology company that develops and manufactures innovative immune cell and gene therapies for the treatment of hematological malignancies and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juventas Cell Therapy Ltd. Comparables
Compare Juventas Cell Therapy Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hrain Biotechnology Co., Ltd. | 88% | |
| Imunopharm Technology Co., Ltd. | 87% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 86% |
For institutional investors. Book with your work email.
Juventas Cell Therapy Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 12, 2021 | ||||
| Series B | Nov 19, 2020 | ||||
| Series A Extension | Jul 9, 2019 | ||||
| Series A | Dec 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Juventas Cell Therapy Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B |
| CCIC Capital | Series C |
| China International Capital Corporation | Series C |
| Dalton Venture | Series A, Series A Extension |
| Tianjin Venture Capital Management Co., Ltd. | Series B, Series C |
| Oceanpine Capital | Series C |
| Delian Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 65% MoM, reaching 2.7K.
- Nov 19, 2020
$69M round led by Emerging Technology Partners.
For institutional investors. Book with your work email.
Juventas Cell Therapy Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Juventas Cell Therapy Ltd.'s valuation, stock price, and market status.
Is Juventas Cell Therapy Ltd. a public or private company?
Juventas Cell Therapy Ltd. is a private company.
What is the current stock price of Juventas Cell Therapy Ltd.?
Juventas Cell Therapy Ltd. is a private company, so its shares have no public market price. Caplight tracks Juventas Cell Therapy Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Juventas Cell Therapy Ltd. worth (valuation)?
Juventas Cell Therapy Ltd.'s valuation is estimated at $263.0M based on funding round data.
Can I buy Juventas Cell Therapy Ltd. stock?
Juventas Cell Therapy Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Juventas Cell Therapy Ltd.'s last funding round?
Juventas Cell Therapy Ltd.'s most recent funding round was Series C on July 12, 2021.
Who are the main investors in Juventas Cell Therapy Ltd.?
Key investors in Juventas Cell Therapy Ltd. include CCIC Capital, China International Capital Corporation, Oceanpine Capital, Danlu Capital, Sinovation Ventures.
Will Juventas Cell Therapy Ltd. IPO soon?
No public IPO plans have been announced for Juventas Cell Therapy Ltd..
How can I track Juventas Cell Therapy Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Juventas Cell Therapy Ltd.'s shares on secondary markets.